Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Nandita, Vishwanathan"'
Autor:
Kevin Botelho Ferreira, Asma Benlegrimet, Gabriel Diane, Victor Pasquier, Raphael Guillot, Marc De Poli, Loïc Chappuis, Nandita Vishwanathan, Jonathan Souquet, Hervé Broly, Jean‐Marc Bielser
Publikováno v:
Biotechnology progressREFERENCES. 38(4)
Implementation of continuous in lieu of batch upstream processing (USP) and downstream process (DSP) for the production of recombinant therapeutic protein is a significant paradigm change. The present report describes how the first kilograms of monoc
Autor:
null Kevin Botelho Ferreira, null Asma Benlegrimet, null Gabriel Diane, null Victor Pasquier, null Raphael Guillot, null Marc De Poli, null Loïc Chappuis, null Nandita Vishwanathan, null Jonathan Souquet, null Hervé Broly, null Jean‐Marc Bielser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::daa0c07a3f13087f41a6378c290c01d1
https://doi.org/10.1002/btpr.3259/v2/response1
https://doi.org/10.1002/btpr.3259/v2/response1
Autor:
Nandita Vishwanathan, Ziomara P. Gerdtzen, Wei Shou Hu, Nicholas J. Baltes, Alicia T. Lucero, Camila A Wilkens
Publikováno v:
Journal of Chemical Technology & Biotechnology. 94:1488-1498
Autor:
Wei Shou Hu, Hsu Yuan Fu, Sofie A. O'Brien, Nandita Vishwanathan, Liang Zhao, Arpan Bandyopadhyay
Publikováno v:
Biotechnology and Bioengineering. 116:41-53
Chinese hamster ovary cells, commonly used in the production of therapeutic proteins, are aneuploid. Their chromosomes bear structural abnormality and undergo changes in structure and number during cell proliferation. Some production cell lines are u
Autor:
Nandita Vishwanathan, Hsu Yuan Fu, Arpan Bandyopadhyay, Wei Shou Hu, Kathryn C. Johnson, Nathan M. Springer
Publikováno v:
Biotechnology and Bioengineering. 114:1903-1908
Chinese Hamster Ovary (CHO) cells are aneuploid in nature. The genome of recombinant protein producing CHO cell lines continuously undergoes changes in its structure and organization. We analyzed nine cell lines, including parental cell lines, using
Publikováno v:
Biotechnology and Bioengineering. 114:1583-1592
In the past few years, transcriptome analysis has been increasingly employed to better understand the physiology of Chinese hamster ovary (CHO) cells at a global level. As more transcriptome data accumulated, meta-analysis on data sets collected from
Autor:
Nitya M. Jacob, Mohit Sharma, Huong Le, Kevin A. T. Silverstein, Kathryn C. Johnson, George Karypis, Wei Shou Hu, Joann Mudge, Thiruvarangan Ramaraj, Hsu Yuan Fu, Nandita Vishwanathan, Getiria Onsongo, Arpan Bandyopadhyay
Publikováno v:
Biotechnology Journal. 11:1151-1157
Chinese hamster Ovary (CHO) cell lines are the dominant industrial workhorses for therapeutic recombinant protein production. The availability of genome sequence of Chinese hamster and CHO cells will spur further genome and RNA sequencing of producin
Autor:
Arpan A, Bandyopadhyay, Sofie A, O'Brien, Liang, Zhao, Hsu-Yuan, Fu, Nandita, Vishwanathan, Wei-Shou, Hu
Publikováno v:
Biotechnology and bioengineering. 116(1)
Chinese Hamster Ovary (CHO) cells, commonly used in the production of therapeutic proteins, are aneuploid. Their chromosomes bear structural abnormality and undergo changes in structure and number during cell proliferation. Some production cell lines
Publikováno v:
Biotechnology Letters. 37:1553-1564
At the core of a biomanufacturing process for recombinant proteins is the production cell line. It influences the productivity and product quality. Its characteristics also dictate process development, as the process is optimized to complement the pr
Autor:
Nandita Vishwanathan, Nitya M. Jacob, Hsu Yuan Fu, Wei Shou Hu, Huong Le, Dong-Yup Lee, Andrew Yongky, Kathryn C. Johnson, Faraaz N.K. Yusufi
Publikováno v:
Biotechnology and Bioengineering. 112:965-976
Transcriptomics is increasingly being used on Chinese hamster ovary (CHO) cells to unveil physiological insights related to their performance during production processes. The rich transcriptome data can be exploited to provide impetus for systems inv